Aurora Cannabis Inc key statistics and ratios
In fiscal 2026, Aurora Cannabis Inc had return on equity of -25.9%, a net margin of -42.4%, debt equal to 0.0% of equity and a current ratio of 5.94. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.
Financial ratios
| Fiscal year | 2019Jun 2018 | 2020Jun 2019 | 2021Jun 2020 | 2022Jun 2021 | 2023Jun 2022 | 2024Mar 2024 | 2025Mar 2025 | 2026Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Gross margin | 78.8% | 58.0% | −7.4% | −8.8% | 9.6% | 48.9% | 62.6% | 42.6% |
| Operating margin | −173.5% | −129.6% | −173.3% | −115.3% | −104.6% | −16.7% | 1.7% | — |
| Net margin | 130.3% | −119.5% | <−999% | −282.2% | −776.0% | −25.7% | 0.6% | −42.4% |
| Free-cash-flow margin | −396.1% | −247.0% | — | −107.5% | −64.4% | −25.4% | 5.5% | −4.2% |
| Return on equity | 4.8% | −9.8% | −99.3% | −33.6% | −125.8% | −11.1% | 0.3% | −25.9% |
| Return on assets | 3.9% | −7.9% | −78.4% | −26.1% | −92.2% | −7.0% | 0.2% | −19.2% |
| Asset turnover | 0.03 | 0.07 | 0.06 | 0.09 | 0.12 | 0.27 | 0.34 | 0.45 |
| Current ratio | 2.92 | 1.51 | 1.53 | 5.72 | 5.69 | 3.42 | 4.31 | 5.94 |
| Debt to equity | 0.8% | 3.2% | 9.5% | — | 0.0% | 10.2% | 10.9% | 0.0% |
| Interest cover (operating income ÷ interest) | — | n/m | n/m | n/m | n/m | n/m | 0.6x | — |
| Effective tax rate | 10.5% | — | — | — | — | — | 13.6% | — |
| R&D as % of revenue | 3.0% | 6.0% | 9.7% | 4.7% | 4.7% | 1.3% | 1.3% | 1.3% |
| Capital spending as % of revenue | 248.1% | 168.7% | — | 21.6% | 14.6% | 0.0% | 0.0% | 0.0% |
| Free cash flow ÷ net income | −303.9% | — | — | — | — | — | >999% | — |
Financial health
- Short-term assets cover short-term liabilities $285m of assets due within a year against $48m of liabilities due within a year.
- Short-term assets cover long-term liabilities $285m short-term assets against $16m of longer-dated liabilities.
- More cash than debt $46m of cash against $0 of debt.
- Debt below 40% of shareholders' equity Debt is 0% of equity.
- Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
- A year's operating cash flow covers at least 20% of debt No debt to cover.
- Operating profit covers interest at least five times over Interest not separately reported. Not assessable.
Moat
Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: Medium.
Compare with peers
- Vanda Pharmaceuticals Inc. statistics
- Harrow, Inc. statistics
- Organigram Global Inc. statistics
- Biote Corp. statistics
- Kamada LTD statistics
Head to head: ACB vs VNDAACB vs HROWACB vs OGI
More: Pharmaceuticals stocks compared, Health Care sector, rankings of US companies